Navigation Links
Type 2 Diabetes: An Epidemic Among America's Youth

HOUSTON, May 18 /PRNewswire-USNewswire/ -- With the number of children suffering from type 2 diabetes growing at an alarming rate, physicians gathered Saturday to discuss strategies for prevention and treatment of the disease among children and adolescents at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress.


"Type 2 diabetes is extremely complex," said A. Jay Cohen, MD, FACE, session moderator and pediatric endocrinologist. "The rapid rise in obesity, physical inactivity and the consumption of excessive calories seems to have led to the epidemic of children with type 2 diabetes."

The National Institutes of Health (NIH) is conducting two clinical trials in order to identify the children at risk for type 2 diabetes and to demonstrate the effectiveness of lifestyle intervention among youth. The first trial, HEALTHY, is following a group of about 6,400 children through middle school, from sixth to eighth grade, to determine if modifications in exercise programs and nutrition in the school environment can reduce the risk of children having the disease. Researchers are tracking the youth's body mass indices (BMIs), fasting glucose levels and fasting insulin levels to show the health benefits of lifestyle adjustments. TODAY, the second trial, is exploring the best treatment options for children with type 2 diabetes.

"It is imperative to expose the social, behavioral and environmental factors which have led to this epidemic," said Francine R. Kaufman, MD, pediatric endocrinologist and Study Chair of both trials.

Children with type 2 diabetes may be afflicted with other conditions associated with type 2 diabetes, including obesity, hypertension, hyperlipidemia (elevated cholesterol), and potential risks of infertility such as Polycystic Ovarian Syndrome. These youth also have an increased risk of developing long-term complications, including heart disease, stroke, kidney disease, and nerve damage.

With results from the HEALTHY trial anticipated to be released this fall, Dr. Kaufman remains optimistic: "The research from these trials will allow us to identify and implement the necessary lifestyle changes that will ultimately foster the health and well-being of not only those at risk but generations of children to come."

For more information about diabetes, download the American College of Endocrinology's (ACE) "Power of Prevention(R)" Magazine here. The magazine features medical information on prediabetes, type 1 and type 2 diabetes, diabetes complications, and tips on how diabetes patients can best prepare for disaster.

A short, one page bio and high resolution photo of Francine R. Kaufman, MD, is available by clicking here.

About AACE

AACE is a professional medical organization with more than 6,200 members in the United States and 92 other countries. Founded in 1991, AACE is dedicated to the optimal care of patients with endocrine problems. AACE initiatives inform the public about endocrine disorders. AACE also conducts continuing education programs for clinical endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine diseases such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity.

SOURCE American Association of Clinical Endocrinologists
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Screening for Ischemia in Asymptomatic Patients With Type 2 Diabetes: Five- Year Outcomes in the DIAD Study
2. Epidemics of Both Type 1 Diabetes (Insulin Dependent) and Type 2 Diabetes (Obesity Related) Are Linked to Immunization
3. AIDS Action Council Statement on World AIDS Day 2007: Leadership Needed for a National Strategy to Stop the AIDS Epidemic
4. Autism Genes Discovered; Help Shape Connections Among Brain Cells
5. Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference
6. Eight-Year Melanoma Remission is Among Early Cancer Treatment Results
7. TriMix Gel Achieves Success Among Men Who Have Failed to Achieve Erections With Viagra, Levitra and Cialis Type Tablets
8. Study Finds Disparities in Breast Cancer Treatment Even Among Fully-Insured African-American and Caucasian Women
9. Study Shows Physician Judgment is Important in Reducing Rate of RSV-Related Hospitalizations Among High-Risk Infants
10. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
11. Influenza Vaccination Rates Among Health Care Personnel Remain Well Below National Goal
Post Your Comments:
(Date:10/11/2017)... -- Caris Life Sciences ® , a leading innovator in ... medicine, today announced that St. Jude Medical Center,s Crosson ... as its 17 th member. Through participation with ... Institute will help develop standards of care and best ... cancer treatment more precise and effective. ...
(Date:10/7/2017)... --  Provista, a proven leader in the supply ... power, today announced a new resource area on ... is the online home for case studies, articles on ... releases, slideshows and events. ... at their fingertips, viewers can also watch short videos ...
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, Inc. ... Day Software and Consulting, LLC , and named its ... Software, based in Tennessee , will ... Day expands EnvoyHealth,s service offerings for health care partners ... "In an interoperable world, ...
Breaking Medicine Technology:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
(Date:10/12/2017)... ... , ... Health Literacy Innovations (HLI), creator of the Health ... Cancer Patient Education Network (CPEN), an independent professional organization that shares best practices ... , As CPEN’s strategic partner, HLI will help support CPEN members by ...
Breaking Medicine News(10 mins):